Evidence map›Paper›PMID 30413623›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.

Ina Klusmann, Kai Wohlberedt, Anna Magerhans, Federico Teloni, Jan O Korbel, Matthias Altmeyer, Matthias Dobbelstein

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. The expanding MDM2 universe.Cell death and differentiation · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Transcription-Replication Conflicts: Unlocking New Frontiers in Cancer.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  9. Article
  10. Z-form DNA-RNA hybrid blocks DNA replication.Nucleic acids research · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ina KlusmannInstitute of Molecular Oncology, Göttingen Center of Molecular Biosciences, University Medical Center Göttingen, D-37077 Göttingen, Germany.
Kai WohlberedtInstitute of Molecular Oncology, Göttingen Center of Molecular Biosciences, University Medical Center Göttingen, D-37077 Göttingen, Germany.
Anna MagerhansInstitute of Molecular Oncology, Göttingen Center of Molecular Biosciences, University Medical Center Göttingen, D-37077 Göttingen, Germany.
Federico TeloniDepartment of Molecular Mechanisms of Disease, University of Zurich, CH-8507 Zurich, Switzerland.
Jan O KorbelEuropean Molecular Biology Laboratory, 69117 Heidelberg, Germany.
Matthias AltmeyerDepartment of Molecular Mechanisms of Disease, University of Zurich, CH-8507 Zurich, Switzerland.
Matthias DobbelsteinInstitute of Molecular Oncology, Göttingen Center of Molecular Biosciences, University Medical Center Göttingen, D-37077 Göttingen, Germany; mdobbel@uni-goettingen.de.ORCID 0000-0001-5052-3967
Universitätsmedizin Göttingen · DEUniversity of Zurich · CHEuropean Molecular Biology Laboratory · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The p53-Mdm2 system is key to tumor suppression. We have recently reported that p53 as well as Mdm2 are capable of supporting DNA replication fork progression. On the other hand, we found that Mdm2 is a modifier of chromatin, modulating polycomb repressor complex (PRC)-driven histone modifications. Here we show that, similar to Mdm2 knockdown, the depletion of PRC members impairs DNA synthesis, as determined in fiber assays. In particular, the ubiquitin ligase and PRC1 component RNF2/Ring1B is required to support DNA replication, similar to Mdm2. Moreover, the Ring finger domain of Mdm2 is not only essential for its ubiquitin ligase activity, but also for proper DNA replication. Strikingly, Mdm2 overexpression can rescue RNF2 depletion with regard to DNA replication fork progression, and vice versa, strongly suggesting that the two ubiquitin ligases perform overlapping functions in this context. H2A overexpression also rescues fork progression upon depletion of Mdm2 or RNF2, but only when the ubiquitination sites K118/K119 are present. Depleting the H2A deubiquitinating enzyme BAP1 reduces the fork rate, suggesting that both ubiquitination and deubiquitination of H2A are required to support fork progression. The depletion of Mdm2 elicits the accumulation of RNA/DNA hybrids, suggesting R-loop formation as a mechanism of impaired DNA replication. Accordingly, RNase H overexpression or the inhibition of the transcription elongation kinase CDK9 each rescues DNA replication upon depletion of Mdm2 or RNF2. Taken together, our results suggest that chromatin modification by Mdm2 and PRC1 ensures smooth DNA replication through the avoidance of R-loop formation.

Indexed as

DNA ReplicationCell Line, TumorChromatinDNAHistonesHumansPolycomb Repressive Complex 1Protein DomainsProto-Oncogene Proteins c-mdm2RNATumor Suppressor ProteinsUbiquitinationUbiquitin ThiolesteraseBAP1 protein, humanChromatinDNAHistonesMDM2 protein, humanPolycomb Repressive Complex 1Proto-Oncogene Proteins c-mdm2RNARNF2 protein, humanTumor Suppressor ProteinsUbiquitin ThiolesterasehistoneMdm2p53RNF2ubiquitin

Identifiers

PMID30413623
PMCPMC6275510
OpenAlexW2900444294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.